Bcl-xL antagonist 2

Catalog No. :
ACCAUP402
CAS No. :
1235032-75-3
Molecular Formula :
C21H16N4O3S2
Molecular Weight :
436.52

IUPAC Name:2-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)thiazole-4-carboxylic acid

Bcl-xL antagonist 2 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$115.00Login to see priceInquiryInquiry
5mg98%$256.00Login to see priceInquiryInquiry
10mg98%$393.00Login to see priceInquiryInquiry
25mg98%$660.00Login to see priceInquiryInquiry
50mg98%$927.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBcl-xL antagonist 2
IUPAC Name2-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)thiazole-4-carboxylic acid
Molecular FormulaC21H16N4O3S2
Molecular Weight436.52
SMILESO=C(C1=CSC(N2CC3=C(C=CC=C3C(NC4=NC5=CC=CC=C5S4)=O)CC2)=N1)O
InChI KeyPHCCZZHEZZPUGG-UHFFFAOYSA-N
SynonymPHCCZZHEZZPUGG-UHFFFAOYSA-N;Bcl-xL antagonist 2;Bcl xL antagonist 2,BclxL antagonist 2;4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-;Bcl-xL antagonist 2, 10 mM in DMSO
CAS No.1235032-75-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCAUP402 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCAUP402 route product structure diagram
    ACCAUP4021235032-75-3
Inquiry

2. ACCAUP402 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCAUP402 route product structure diagram
    ACCAUP4021235032-75-3
Inquiry

Comments (0)